1278 related articles for article (PubMed ID: 11062068)
1. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
2. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
5. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
7. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts.
Brondello JM; McKenzie FR; Sun H; Tonks NK; Pouysségur J
Oncogene; 1995 May; 10(10):1895-904. PubMed ID: 7761091
[TBL] [Abstract][Full Text] [Related]
8. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
[TBL] [Abstract][Full Text] [Related]
10. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.
Saxena M; Williams S; Taskén K; Mustelin T
Nat Cell Biol; 1999 Sep; 1(5):305-11. PubMed ID: 10559944
[TBL] [Abstract][Full Text] [Related]
13. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
14. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
15. Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.
Lornejad-Schäfer MR; Schäfer C; Graf D; Häussinger D; Schliess F
Biochem J; 2003 Apr; 371(Pt 2):609-19. PubMed ID: 12529177
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation.
Lai K; Wang H; Lee WS; Jain MK; Lee ME; Haber E
J Clin Invest; 1996 Oct; 98(7):1560-7. PubMed ID: 8833904
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK
Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.
Brunet A; Roux D; Lenormand P; Dowd S; Keyse S; Pouysségur J
EMBO J; 1999 Feb; 18(3):664-74. PubMed ID: 9927426
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts.
Dorfman K; Carrasco D; Gruda M; Ryan C; Lira SA; Bravo R
Oncogene; 1996 Sep; 13(5):925-31. PubMed ID: 8806681
[TBL] [Abstract][Full Text] [Related]
20. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
